A
Alessia Alunno
Researcher at University of Perugia
Publications - 256
Citations - 6763
Alessia Alunno is an academic researcher from University of Perugia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 214 publications receiving 4720 citations. Previous affiliations of Alessia Alunno include University of L'Aquila & University of Brescia.
Papers
More filters
Journal ArticleDOI
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis,Myrto Kostopoulou,Alessia Alunno,Martin Aringer,Ingeborg M. Bajema,John Boletis,Ricard Cervera,Andrea Doria,Caroline Gordon,Marcello Govoni,Frédéric Houssiau,David Jayne,Marios Kouloumas,Annegret Kuhn,Janni Lisander Larsen,Kirsten Lerstrøm,Gabriella Moroni,Marta Mosca,Matthias Schneider,Josef S Smolen,Elisabet Svenungsson,Vladimir Tesar,Angela Tincani,Anne Troldborg,Ronald F van Vollenhoven,Jörg Wenzel,George Bertsias,Dimitrios T. Boumpas +27 more
TL;DR: The updated recommendations provide physicians and patients with updated consensus guidance on the management of SLE, combining evidence-base and expert-opinion, based on emerging new evidence.
Journal ArticleDOI
Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients
Chiara Baldini,Pasquale Pepe,Luca Quartuccio,Roberta Priori,E. Bartoloni,Alessia Alunno,Angelica Gattamelata,M. Maset,M. Modesti,Antonio Tavoni,Salvatore De Vita,Roberto Gerli,Guido Valesini,Stefano Bombardieri +13 more
TL;DR: This study confirmed that the prevalence of the pSS high-risk subset for severe systemic manifestations is ∼15%.
Journal ArticleDOI
Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new.
Alessia Alunno,Elena Bartoloni,Onelia Bistoni,Giuseppe Nocentini,Simona Ronchetti,Sara Caterbi,Valentina Valentini,Carlo Riccardi,Roberto Gerli +8 more
TL;DR: The current knowledge about Treg and Th17 cells interplay in SLE will be discussed and targeting Treg/Th17 balance for therapeutic purposes may represent an intriguing and useful tool for SLE treatment in the next future.
Journal ArticleDOI
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
Francesco Carubbi,Paola Cipriani,Alessandra Marrelli,Paola Di Benedetto,Piero Ruscitti,Onorina Berardicurti,Ilenia Pantano,Vasiliki Liakouli,Saverio Alvaro,Alessia Alunno,Antonio Manzo,Francesco Ciccia,Roberto Gerli,Giovanni Triolo,Roberto Giacomelli +14 more
TL;DR: This study demonstrated that RTX treatment results in a faster and more pronounced decrease of ESSDAI and other clinical parameters compared to DMARDs treatment, and showed that RTX is a safe and effective agent to be employed in pSS patients with systemic, extra-glandular involvement.
Journal Article
One year in review 2017: pathogenesis of rheumatoid arthritis.
Francesca Angelotti,Alice Parma,Giacomo Cafaro,Riccardo Capecchi,Alessia Alunno,Ilaria Puxeddu +5 more
TL;DR: New insights in RA pathogenesis are reported, resulting from a literature research date published in the last year, to identify new targets for the development of disease-modifying therapies.